Johnson & Johnson Innovation - JJDC, Inc. - Sep 15, 2023 Form 4/A Insider Report for CVRx, Inc. (CVRX)

Role
10%+ Owner
Signature
Johnson & Johnson Innovation - JJDC, Inc., By: /s/ Jill McManus, Assistant Treasurer
Stock symbol
CVRX
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4/A
Date filed
2/2/2024, 05:47 PM
Date Of Original Report
Sep 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Stock Option (Right to Buy) Other -237 -100% 0 Sep 15, 2023 Common Stock 237 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -158 -100% 0 Sep 15, 2023 Common Stock 158 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -189 -100% 0 Sep 15, 2023 Common Stock 189 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -165 -100% 0 Sep 15, 2023 Common Stock 165 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -118 -100% 0 Sep 15, 2023 Common Stock 118 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -71 -100% 0 Sep 15, 2023 Common Stock 71 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -23 -100% 0 Sep 15, 2023 Common Stock 23 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -85 -100% 0 Sep 15, 2023 Common Stock 85 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -758 -100% 0 Sep 15, 2023 Common Stock 758 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -489 -100% 0 Sep 15, 2023 Common Stock 489 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -758 -100% 0 Sep 15, 2023 Common Stock 758 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -300 -100% 0 Sep 15, 2023 Common Stock 300 $0.24 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -758 -100% 0 Sep 15, 2023 Common Stock 758 $1.19 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -142 -100% 0 Sep 15, 2023 Common Stock 142 $1.19 Direct F1, F2, F3
transaction CVRX Stock Option (Right to Buy) Other -758 -100% 0 Sep 15, 2023 Common Stock 758 $3.96 Direct F1, F2, F4
transaction CVRX Stock Option (Right to Buy) Other -1.26K -100% 0 Sep 15, 2023 Common Stock 1.26K $5.14 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Johnson & Johnson Innovation - JJDC, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law,
F2 (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein.
F3 Fully vested.
F4 Vests as to 1/48th of the shares each month commencing January 6, 2020.
F5 Vests as to 1/48th of the shares each month commencing January 11, 2021.